HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC

Clinical trials for HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC explained in plain language.

Never miss a new study

Get alerted when new HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC trials appear

Sign up with your email to follow new studies for HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope to stop deadly leukemia relapse after transplant

Disease control Not yet recruiting

This study tests whether adding a new drug called asciminib to standard maintenance therapy can better prevent leukemia from returning after a stem cell transplant. Researchers will compare two groups: one receiving the standard drug alone and another receiving the standard drug …

Matched conditions: HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC

Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC

Get alerted when new HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC trials appear

New hope to stop deadly leukemia relapse after transplant